Abstract
1 Seizure control, saliva anticonvulsant concentration, prescribing habits and compliance with anticonvulsant medication have been compared in 86 epileptic subjects attending either a specialist hospital clinic or general practice surgeries. 2 Of all subjects experiencing recurrent seizures 70% had saliva concentrations of phenytoin below the range equivalent to the 'therapeutic range' of plasma concentration. Mean saliva phenytoin concentrations did not differ significantly between the two treatment settings and were low largely because of the low mean dosage prescribed. 3 Eleven subjects in all had no detectable phenytoin in their and could clearly be identified as noncompliant. Freedom from seizures appeared to predispose to poor compliance in these subjects as well as among those admitting repeated omission of doses.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BUCHTHAL F., SVENSMARK O., SCHILLER P. J. Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin. Arch Neurol. 1960 Jun;2:624–630. doi: 10.1001/archneur.1960.03840120030004. [DOI] [PubMed] [Google Scholar]
- Bastiani R. J., Phillips R. C., Schneider R. S., Ullman E. F. Homogenous immunochemical drug assays. Am J Med Technol. 1973 Jun;39(6):211–216. [PubMed] [Google Scholar]
- Bochner F., Hooper W. D., Sutherland J. M., Eadie M. J., Tyrer J. H. Diphenylhydantoin concentrations in saliva. Arch Neurol. 1974 Jul;31(1):57–59. doi: 10.1001/archneur.1974.00490370083014. [DOI] [PubMed] [Google Scholar]
- Cocks D. A., Critchley E. M. Control of epilepsy with a single daily dose of phenytoin sodium. Br J Clin Pharmacol. 1975 Oct;2(5):449–453. doi: 10.1111/j.1365-2125.1975.tb00555.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cook C. E., Amerson E., Poole W. K., Lesser P., O'Tuama L. Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay. Clin Pharmacol Ther. 1975 Dec;18(6):742–747. doi: 10.1002/cpt1975186742. [DOI] [PubMed] [Google Scholar]
- Gibberd F. B., Dunne J. F., Handley A. J., Hazleman B. L. Supervision of epileptic patients taking phenytoin. Br Med J. 1970 Jan 17;1(5689):147–149. doi: 10.1136/bmj.1.5689.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hooper W. D., Tyrer J. H., Eadie M. J. Plasma diphenylhydantoin levels in Australian adults. Aust N Z J Med. 1974 Oct;4(5):449–455. doi: 10.1111/j.1445-5994.1974.tb03216.x. [DOI] [PubMed] [Google Scholar]
- Hopkins A., Scambler G. How doctors deal with epilepsy. Lancet. 1977 Jan 22;1(8004):183–186. doi: 10.1016/s0140-6736(77)91777-9. [DOI] [PubMed] [Google Scholar]
- Kutt H., Haynes J., McDowell F. Some causes of ineffectiveness of diphenylhydantoin. Arch Neurol. 1966 May;14(5):489–492. doi: 10.1001/archneur.1966.00470110033004. [DOI] [PubMed] [Google Scholar]
- MacGee J. Rapid determination of diphenylhydantoin in blood plasma by gas-liquid chromatography. Anal Chem. 1970 Mar;42(3):421–422. doi: 10.1021/ac60285a024. [DOI] [PubMed] [Google Scholar]
- Reynolds E. H., Chadwick D., Galbraith A. W. One drug (phenytoin) in the treatment of epilepsy. Lancet. 1976 May 1;1(7966):923–926. doi: 10.1016/s0140-6736(76)92709-4. [DOI] [PubMed] [Google Scholar]
- Vajda F., Williams F. M., Davidson S., Falconer M. A., Breckenridge A. Human brain, cerebrospinal fluid, and plasma concentrations of diphenylhydantoin and phenobarbital. Clin Pharmacol Ther. 1974 Jun;15(6):597–603. doi: 10.1002/cpt1974156597. [DOI] [PubMed] [Google Scholar]